Gene · 10482
Papers2,989
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,989
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome. | J Virol | 2021 | 34011540 | PubTator, text mining | PubMed |
| Heh2/Man1 may be an evolutionarily conserved sensor of NPC assembly state. | Mol Biol Cell | 2021 | 34010011 | PubTator, text mining | PubMed |
| Functions of RNA N6-methyladenosine modification in acute myeloid leukemia. | Biomark Res | 2021 | 34001273 | PubTator, text mining | PubMed |
| Transcription, mRNA Export, and Immune Evasion Shape the Codon Usage of Viruses. | Genome Biol Evol | 2021 | 33988683 | PubTator, text mining | PubMed |
| Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. | Clin Microbiol Rev | 2021 | 33980688 | PubTator, text mining | PubMed |
| Tumor Spheroids of an Aggressive Form of Central Neurocytoma Have Transit-Amplifying Progenitor Characteristics with Enhanced EGFR and Tumor Stem Cell Signaling. | Exp Neurobiol | 2021 | 33972466 | PubTator, text mining | PubMed |
| Surgical considerations for atrial functional regurgitation of the mitral and tricuspid valves based on the etiological mechanism. | Gen Thorac Cardiovasc Surg | 2021 | 33970433 | PubTator, text mining | PubMed |
| Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches. | F1000Res | 2021 | 33968364 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. | PLoS Pathog | 2021 | 33956915 | PubTator, text mining | PubMed |
| N6 -methyladenosine Steers RNA Metabolism and Regulation in Cancer. | Cancer Commun (Lond) | 2021 | 33955720 | PubTator, text mining | PubMed |
| TAP Test Image Dynamic Tracking Study after Thyroid Cancer Surgery and after Radiotherapy and Chemotherapy. | Comput Math Methods Med | 2021 | 33953794 | PubTator, text mining | PubMed |
| aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis. | Ann Clin Transl Neurol | 2021 | 33949790 | PubTator, text mining | PubMed |
| Mutations and Protein Interaction Landscape Reveal Key Cellular Events Perturbed in Upper Motor Neurons with HSP and PLS. | Brain Sci | 2021 | 33947096 | PubTator, text mining | PubMed |
| The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export. | Mol Cell Biol | 2021 | 33941617 | PubTator, text mining | PubMed |
| Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers. | Front Oncol | 2021 | 33928028 | PubTator, text mining | PubMed |
| Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration. | Int J Mol Sci | 2021 | 33920577 | PubTator, text mining | PubMed |
| Distorted Porphyrins with High Stability: Synthesis and Characteristic Electronic Properties of Mono- and Di-Nuclear Tricarbonyl Rhenium Tetraazaporphyrin Complexes. | Chemistry | 2021 | 33913188 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease. | Front Mol Biosci | 2021 | 33912591 | PubTator, text mining | PubMed |
| Inhibition of Host Gene Expression by KSHV: Sabotaging mRNA Stability and Nuclear Export. | Front Cell Infect Microbiol | 2021 | 33898329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10482/papers?page=40